Brief: Acurx Pharmaceuticals, Inc. Announces Pricing Of $4.0 Million Registered Direct Offering
16/05/2023 14:28
Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. ANNOUNCES PRICING OF $4.0
MILLION
REGISTERED DIRECT OFFERING
* ACURX PHARMACEUTICALS: AGREEMENT WITH A SINGLE
INSTITUTIONAL
INVESTOR TO BUY 1.3 MILLION SHARES AT COMBINED EFFECTIVE
PURCHASE PRICE OF $3.00 PER SHARE
Source text for Eikon: ID:nPn8VBBwKa
Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program